Palisade Bio (PALI) Retained Earnings (2016 - 2025)
Historic Retained Earnings for Palisade Bio (PALI) over the last 16 years, with Q3 2025 value amounting to -$143.8 million.
- Palisade Bio's Retained Earnings fell 846.61% to -$143.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$143.8 million, marking a year-over-year decrease of 846.61%. This contributed to the annual value of -$135.9 million for FY2024, which is 1188.25% down from last year.
- Latest data reveals that Palisade Bio reported Retained Earnings of -$143.8 million as of Q3 2025, which was down 846.61% from -$141.0 million recorded in Q2 2025.
- Palisade Bio's Retained Earnings' 5-year high stood at -$95.7 million during Q3 2021, with a 5-year trough of -$240.5 million in Q1 2021.
- For the 5-year period, Palisade Bio's Retained Earnings averaged around -$125.9 million, with its median value being -$120.0 million (2023).
- As far as peak fluctuations go, Palisade Bio's Retained Earnings surged by 5906.53% in 2021, and later plummeted by 1357.04% in 2023.
- Quarter analysis of 5 years shows Palisade Bio's Retained Earnings stood at -$95.7 million in 2021, then decreased by 14.08% to -$109.2 million in 2022, then decreased by 11.28% to -$121.5 million in 2023, then fell by 11.88% to -$135.9 million in 2024, then decreased by 5.8% to -$143.8 million in 2025.
- Its Retained Earnings was -$143.8 million in Q3 2025, compared to -$141.0 million in Q2 2025 and -$138.2 million in Q1 2025.